+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Trial Equipment & Ancillary Solutions Market by Component, Phase, Therapeutic Area, End-User - Global Forecast to 2030- Product Image
Clinical Trial Equipment & Ancillary Solutions Market by Component, Phase, Therapeutic Area, End-User - Global Forecast to 2030- Product Image
Sale

Clinical Trial Equipment & Ancillary Solutions Market by Component, Phase, Therapeutic Area, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5612809
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical trial equipment and ancillary solutions market is undergoing a significant transformation as companies adopt advanced technologies and new operational strategies to address increasing complexity and evolving regulations. Senior stakeholders now face opportunities and risks shaped by digitalization, global supply dynamics, and a powerful shift toward patient-focused trial methodologies.

Market Snapshot: Clinical Trial Equipment & Ancillary Solutions

The Clinical Trial Equipment & Ancillary Solutions Market is valued at USD 4.58 billion in 2024, projected to reach USD 5.00 billion in 2025, and is expected to grow at a CAGR of 8.84% to USD 7.62 billion by 2030. This sector connects the core of clinical research with state-of-the-art technology, creating opportunities for operational resilience and innovation. Decentralized trial models, real-time digital platforms, and next-generation logistics are changing the landscape for life sciences organizations, CROs, and technology partners competing in a dynamic global environment.

Scope & Segmentation

This report provides in-depth analysis across component, phase, therapeutic area, end-user, and regional perspectives, reflecting the evolving demands of the clinical trial ecosystem. The assessment includes comprehensive segmentation to ensure actionable intelligence for strategic planning.

  • Component: Ancillary Solutions, Equipment
  • Ancillary Solutions: Central Lab Services, Clinical Trial Management Systems (CTMS), Data Management & Analytics Services, Electronic Data Capture (EDC) Systems, Interactive Response Technology (IRT), Patient Engagement Solutions, Supply Chain & Logistics Solutions
  • Equipment: Drug Dispensing/Packaging Devices, Imaging Equipment, Laboratory Instruments, Monitoring Device
  • Trial Phase: Phase I, Phase II, Phase III, Phase IV
  • Therapeutic Area: Cardiology, Immunology, Infectious Diseases, Neurology, Oncology
  • End-User: Academic/Research Institutions, Biotechnology Firms, Contract Research Organizations (CROs), Medical Device Companies, Pharmaceutical Companies
  • Regional Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
  • Technology Highlights: Digital transformation, integration of AI in data platforms, wearable and remote monitoring, cloud-based supply chain tools, and use of blockchain for logistics traceability
  • Featured Companies: Almac Group Limited, Ancillare LP, Avantor Inc., Axelerist, B. Braun SE, Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Dassault Systèmes SE, Eppendorf SE, Eurofins Scientific SE, Oracle Corporation, Parexel International Corporation, Veeva Systems Inc., and others

Key Takeaways for Senior Decision-Makers

  • Digital and decentralized trial models enable real-time data collection, reducing on-site demands and broadening access to diverse patient populations.
  • Centralized analytics platforms and AI-powered tools are streamlining protocol adherence, advancing risk management, and enabling proactive monitoring to boost trial efficiency.
  • Modular, automated drug dispensing and imaging equipment are supporting rapidly evolving protocol requirements while shortening turnaround times in both early- and late-phase trials.
  • Patient engagement solutions, including mobile and telehealth applications, foster improved retention and data quality—critical as trials become more geographically dispersed.
  • Regional investment in laboratory infrastructure and supply chain agility is shaping global competitive dynamics, as sponsors seek to balance speed, cost, and regulatory compliance.

Tariff Impact: Managing Policy Risks in Clinical Trial Equipment & Ancillary Solutions

New US tariffs starting in 2025 present added procurement complexity for organizations relying on imported clinical trial devices and consumables. Increased duties on laboratory and imaging equipment are expected to drive stakeholders to rethink sourcing models, explore regional manufacturing, and deepen value-based supplier relationships. Effective risk mitigation now emphasizes dual-sourcing, agile inventory strategies, and rigorous supply chain transparency. These policy shifts also foster innovation in domestic manufacturing, offering a strategic edge to organizations able to rapidly adapt supply lines in response to evolving trade conditions.

Methodology & Data Sources

This report is underpinned by a multi-stage methodology, combining comprehensive secondary research—regulatory documents, industry white papers, financial filings—with primary interviews of executives at leading pharmaceutical, CRO, and technology organizations. Data triangulation ensures validity across geographic segments, while insights are enhanced by expert panel reviews and real-world case analysis.

Why This Report Matters

  • Enables strategic investment and sourcing decisions by mapping the clinical trial equipment and ancillary solutions landscape.
  • Facilitates risk mitigation by highlighting the impact of new tariffs, regulatory directions, and trends in decentralized trials.
  • Delivers actionable intelligence tailored for pharmaceutical, biotechnology, and device company leaders, CRO executives, and research institution directors seeking competitive advantage.

Conclusion

This report delivers targeted insights for guiding investment, vendor selection, and operational optimization in the clinical trial equipment and ancillary solutions market. Industry leaders can leverage its findings to strengthen supply resilience, accelerate innovation, and drive superior patient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Trial Equipment & Ancillary Solutions Market, by Component
8.1. Introduction
8.2. Ancillary Solutions
8.2.1. Central Lab Services
8.2.2. Clinical Trial Management Systems (CTMS)
8.2.3. Data Management & Analytics Services
8.2.4. Electronic Data Capture (EDC) Systems
8.2.5. Interactive Response Technology (IRT)
8.2.6. Patient Engagement Solutions
8.2.7. Supply Chain & Logistics Solutions
8.3. Equipments
8.3.1. Drug Dispensing/Packaging Devices
8.3.2. Imaging Equipment
8.3.3. Laboratory Instruments
8.3.4. Monitoring Device
9. Clinical Trial Equipment & Ancillary Solutions Market, by Phase
9.1. Introduction
9.2. Phase I
9.3. Phase II
9.4. Phase III
9.5. Phase IV
10. Clinical Trial Equipment & Ancillary Solutions Market, by Therapeutic Area
10.1. Introduction
10.2. Cardiology
10.3. Immunology
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
11. Clinical Trial Equipment & Ancillary Solutions Market, by End-User
11.1. Introduction
11.2. Academic/Research Institutions
11.3. Biotechnology Firms
11.4. Contract Research Organizations (CROs)
11.5. Medical Device Companies
11.6. Pharmaceutical Companies
12. Americas Clinical Trial Equipment & Ancillary Solutions Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Clinical Trial Equipment & Ancillary Solutions Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Israel
13.17. Norway
13.18. Poland
13.19. Switzerland
14. Asia-Pacific Clinical Trial Equipment & Ancillary Solutions Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Almac Group Limited
15.3.2. Ancillare, LP
15.3.3. Avantor, Inc.
15.3.4. Axelerist
15.3.5. B. Braun SE
15.3.6. Bio-Rad Laboratories, Inc.
15.3.7. Charles River Laboratories International, Inc.
15.3.8. Dassault Systèmes SE
15.3.9. Emsere B.V.
15.3.10. Eppendorf SE
15.3.11. Eurofins Scientific SE
15.3.12. Global Vision Technologies, Inc.
15.3.13. Hitachi, Ltd.
15.3.14. IQVIA Holdings Inc.
15.3.15. Lonza Group Ltd.
15.3.16. MedNet Solutions, Inc.
15.3.17. Myonex, Inc.
15.3.18. Navitas Inc.
15.3.19. Oracle Corporation
15.3.20. Parexel International Corporation
15.3.21. Quanticate International Limited
15.3.22. Quipment SAS
15.3.23. Royal Philips
15.3.24. Thermo Fisher Scientific, Inc.
15.3.25. United Parcel Service, Inc.
15.3.26. Veeva Systems Inc.
15.3.27. Yokogawa Electric Corporation
15.3.28. Zifo Technologies Private Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-CURRENCY
FIGURE 2. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET MULTI-LANGUAGE
FIGURE 3. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CENTRAL LAB SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT SYSTEMS (CTMS), BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DATA MANAGEMENT & ANALYTICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ELECTRONIC DATA CAPTURE (EDC) SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INTERACTIVE RESPONSE TECHNOLOGY (IRT), BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PATIENT ENGAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY SUPPLY CHAIN & LOGISTICS SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY DRUG DISPENSING/PACKAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMAGING EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY LABORATORY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MONITORING DEVICE, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE I, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE II, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE III, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE IV, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ACADEMIC/RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY BIOTECHNOLOGY FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 54. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 55. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 56. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 57. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 58. CANADA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 60. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 67. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 68. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 72. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 73. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 74. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 75. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 76. ARGENTINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 86. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 88. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 89. UNITED KINGDOM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 91. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 92. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 93. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 94. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 95. GERMANY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 97. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 98. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 99. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 101. FRANCE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 103. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 104. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 105. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 106. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 107. RUSSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 109. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 110. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 111. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 112. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 113. ITALY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 115. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 116. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 117. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 118. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 119. SPAIN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 122. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 123. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 125. UNITED ARAB EMIRATES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 134. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 136. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 137. SOUTH AFRICA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 139. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 140. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 141. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 142. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 143. DENMARK CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 145. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 146. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 147. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 148. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 149. NETHERLANDS CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 151. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 152. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 153. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 154. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 155. QATAR CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 157. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 158. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 159. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 160. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 161. FINLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 163. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 164. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 165. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 168. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 169. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 170. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 171. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 172. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 173. ISRAEL CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 175. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 176. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 177. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 179. NORWAY CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 181. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 182. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 183. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 184. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 185. POLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 187. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 188. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 189. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 190. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 191. SWITZERLAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 199. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 200. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 201. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 202. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 203. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 204. CHINA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 206. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 207. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 208. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 209. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 210. INDIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 212. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 213. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 214. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 215. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 216. JAPAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 223. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 224. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 225. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 226. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 227. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 228. SOUTH KOREA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 229. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 230. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 231. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 232. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 233. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 234. INDONESIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 236. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 237. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 238. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 239. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 240. THAILAND CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 241. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 242. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 243. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 244. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 245. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 246. PHILIPPINES CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 247. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 248. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 249. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 250. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 251. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 252. MALAYSIA CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 255. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 256. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 257. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 258. SINGAPORE CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 259. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 260. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 261. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 262. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 263. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
TABLE 264. VIETNAM CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 265. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
TABLE 266. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY ANCILLARY SOLUTIONS, 2018-2030 (USD MILLION)
TABLE 267. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY EQUIPMENTS, 2018-2030 (USD MILLION)
TABLE 268. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN CLINICAL TRIAL EQUIPMENT & ANCILLARY SOLUTIONS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Trial Equipment & Ancillary Solutions market report include:
  • Almac Group Limited
  • Ancillare, LP
  • Avantor, Inc.
  • Axelerist
  • B. Braun SE
  • Bio-Rad Laboratories, Inc.
  • Charles River Laboratories International, Inc.
  • Dassault Systèmes SE
  • Emsere B.V.
  • Eppendorf SE
  • Eurofins Scientific SE
  • Global Vision Technologies, Inc.
  • Hitachi, Ltd.
  • IQVIA Holdings Inc.
  • Lonza Group Ltd.
  • MedNet Solutions, Inc.
  • Myonex, Inc.
  • Navitas Inc.
  • Oracle Corporation
  • Parexel International Corporation
  • Quanticate International Limited
  • Quipment SAS
  • Royal Philips
  • Thermo Fisher Scientific, Inc.
  • United Parcel Service, Inc.
  • Veeva Systems Inc.
  • Yokogawa Electric Corporation
  • Zifo Technologies Private Limited

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.62 Billion
Compound Annual Growth Rate8.8%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033 - Product Image

Clinical Trials Market Forecast Report by Phase, Indication, Study Material, Country and Company 2025-2033

  • Report
  • 220 Pages
  • Global
From
Clinical Trials Market in the US 2025-2029 - Product Image

Clinical Trials Market in the US 2025-2029

  • Report
  • 166 Pages
  • United States
From
North America Clinical Trials Market Size and Forecast Report 2025-2033 - Product Image

North America Clinical Trials Market Size and Forecast Report 2025-2033

  • Report
  • 200 Pages
  • North America
From
KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 - Product Image

KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025

  • Report
  • 75 Pages
  • Global
From
Clinical Trial Equipment and Ancillary Solutions - Global Strategic Business Report - Product Image

Clinical Trial Equipment and Ancillary Solutions - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.